text size: Default style Switch styles (larger text) Switch styles (largest text)
The University of Pittsburgh Alzheimer's Disease Research Center

The University of Pittsburgh Alzheimer Disease Research Center (ADRC) is one of the nation’s leading research centers specializing in the diagnosis of Alzheimer’s disease and related disorders. Through outpatient evaluations, participants and their families receive state-of-the-art diagnostic assessments and contribute to the scientific study of Alzheimer’s disease.


Senior moments or something more?
You walk into a room and forget why you entered in the first place. You can’t quite place a name with a face, or you fail to recall the name of an actor you’ve seen on television recently.  read more »

The Andy Warhol Museum Teams
Up with Pitt’s Alzheimer Disease Research Center


Click here to learn more about the Alzheimer Disease Research Center's partnership with the Andy Warhol Museum.»
We are currently recruiting participants for :

AMBAR Study

Description: The purpose of this study is to determine whether short-term followed by long-term, low-volume plasma exchange (a process of blood filtering) is able to modify Alzheimer Disease patient's cognitive, functional, and behavioral symptoms.

Study Length: 14 months (Six weekly plasmapheresis sessions followed by 12 monthly plasmapheresis sessions)

Study Requirements
  • 55-85 years of age
  • Individuals with a diagnosis of mild to moderate Alzheimer's disease
  • A study partner who will accompany the participant to all clinic visits
Contact:
Donna Simpson, 412-692-2717 or simpsondm@upmc.edu or
MaryAnn Oakley at 412-692-2721 or oakleym@upmc.edu



EXPEDITION 3 Clinical Trial

Description: This study will test the idea that the investigational medication solanezumab will slow the cognitive and functional decline of Alzheimer's Disease (AD) as compared with placebo in participants with mild AD.

Study Length: Approximately 18 months

Study Requirements
  • Individuals with a diagnosis of mild Alzheimer’s disease
  • Ages 55 – 90
  • A study partner who will accompany the participant to all clinic visits
Contact:
Carolyn Rickard at 412-692-2707 mishlercj@upmc.edu or
MaryAnn Oakley at 412-692-2721 or oakleym@upmc.edu



Medication Study for the Treatment of Agitation in Moderate to Severe Alzheimer's Disease

Description: The purpose of this study is to determine whether an investigational medication (ELND005) is effective for reducing behaviors in people with moderate to severe Alzheimer's disease who have agitation/aggression.

Study Length: 12 Weeks

Study Requirements:
  • Diagnosis of moderate to severe Alzheimer's disease with behavior problems/agitation.
  • A study partner who will accompany the participant to all clinic visits.
For more information please contact:
Carolyn Rickard at 412-692-2707 mishlercj@upmc.edu or
MaryAnn Oakley at 412-692-2721 oakleym@upmc.edu


The University of Pittsburgh Alzheimer’s Disease Research Center (ADRC) is looking for volunteers with or without mild memory loss to participate in our research.
You may qualify if:
  • You are 65 years or older with no memory complaints or,
  • You have a memory complaint and think you might have mild memory loss,

    AND

  • You have a “study partner" who can accompany you to clinic visits. A study partner is a family member or close friend who knows you well and can answer questions about your memory and functioning.
Please call the ADRC at 412-692-2700 for more information or to inquire about how you can volunteer for research to help fight Alzheimer’s disease or complete a memory evaluation application and return it to us.


Other studies we are recruiting for »